1 At 24 months, the estimated incidence of
the primary end point was 12.6% in the TAVR group and 14.0% i
2 The primary end point was 2-year progression-free survival.
3 The primary end point was a change in peak oxygen uptake (Vo2
4 The primary end point was a change in the villous height:cryp
5 The primary end point was a composite of death, the need for
6 The primary end point was adjudicated AF lasting 6 or more mi
7 The primary end point was centrally assessed PFS.
8 The primary end point was complete remission (CR) or CR with
9 The primary end point was daily combined symptom-medication s
10 The primary end point was death, myocardial infarction, or un
11 The primary end point was development of HGD or EAC.
12 The primary end point was dual: a composite of all-cause mort
13 The primary end point was endothelial integrity and muscular
14 The primary end point was event-free survival (with an event
15 The primary end point was freedom from repeat coronary revasc
16 The primary end point was incident diverticulitis.
17 The primary end point was major adverse cardiac events define
18 The primary end point was maximal decrease in FEV1 during 10
19 The primary end point was objective response rate evaluated b
20 The primary end point was OS 18 months post-random assignment
21 The primary end point was OS.
22 The primary end point was overall response rate (ORR).
23 The primary end point was overall survival (OS) of patients w
24 The primary end point was overall survival.
25 The primary end point was patient participation in CRC screen
26 The primary end point was PFS; secondary end points included
27 The primary end point was progression-free survival (PFS).
28 The primary end point was progression-free survival by respon
29 The primary end point was reached by 25 ablation patients and
30 The primary end point was remission at 8 weeks.
31 The primary end point was RT-PCR-confirmed, protocol defined,
32 The primary end point was seroconversion or a >/=4-fold rise
33 The primary end point was sustained virologic response at 12
34 The primary end point was target-vessel failure (a composite
35 The primary end point was the annualized rate of asthma exace
36 The primary end point was the change from baseline in LDL cho
37 The primary end point was the change from baseline to months
38 The primary end point was the change in convulsive-seizure fr
39 The primary end point was the change in Hb at day 7.
40 The primary end point was the change in peak VO2 from baselin
41 The primary end point was the composite of aneurysm rupture o
42 The primary end point was the detection of bone lesions at di
43 The primary end point was the development of asthma until age
44 The primary end point was the efficacy of three doses of vacc
45 The primary end point was the identification of the maximum t
46 The primary end point was the incidence of somatic mutations
47 The primary end point was the number of patients no longer re
48 The primary end point was the percentage of patients with dis
49 The primary end-point was the 2007 international working grou
50 The primary end point was treatment efficacy measured as the